OnKure Therapeutics, Inc. (OKUR) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $2K. Most recent filing: Aug. 13, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 13, 2026 filed Aug. 7, 2026 | Manke Isaac Director | $0 | 0 | — | No | |
| Aug. 11, 2026 filed Aug. 7, 2026 | Mathers Edward T Director | $0 | 22,350 | 0% | No | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 7, 2026 | Ratcliffe Liam Director | $0 | 22,350 | 0% | No | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 7, 2026 | Phillips Andrew John Director | $0 | 22,350 | 0% | No | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 7, 2026 | Manke Isaac Director | $0 | 330,600 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free